Research ArticleBasic Science Investigations
Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants
Jan-Philip Meyer, Kimberly J. Edwards, Paul Kozlowski, Marina V. Backer, Joseph M. Backer and Jason S. Lewis
Journal of Nuclear Medicine November 2016, 57 (11) 1811-1816; DOI: https://doi.org/10.2967/jnumed.116.173237
Jan-Philip Meyer
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Kimberly J. Edwards
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Paul Kozlowski
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Marina V. Backer
2SibTech Inc., Brookfield, Connecticut
Joseph M. Backer
2SibTech Inc., Brookfield, Connecticut
Jason S. Lewis
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
3Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; and
4Weill Cornell Medical College, New York, New York
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 11
November 1, 2016
Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants
Jan-Philip Meyer, Kimberly J. Edwards, Paul Kozlowski, Marina V. Backer, Joseph M. Backer, Jason S. Lewis
Journal of Nuclear Medicine Nov 2016, 57 (11) 1811-1816; DOI: 10.2967/jnumed.116.173237